Longevity Science Foundation

07/27/2026

We're pleased to welcome J.P. Morgan Private Bank as a Gold Sponsor of the Invested in Her event, focused on advancing women's health research and building a community of people committed to investing in women.

J.P. Morgan Private Bank works with individuals, families, and institutions to build and preserve wealth across generations, with a deep commitment to thoughtful, values-aligned giving and philanthropy. Through their support of Invested in Her, J.P. Morgan Private Bank brings not only resources but a shared belief that directing capital toward underfunded areas of medicine is both a meaningful and an urgent priority. We are grateful to Matthew E. Seitz and the J.P. Morgan Private Bank team, based in New York City, for their commitment.

Learn more: https://privatebank.jpmorgan.com/nam/en/locations/united-states/connecticut/greenwich

Women shouldn't have to wait decades longer for their health to be properly understood and addressed. It's time to get fully Invested in Her. Join us on August 14th at 7 World Trade Center, Floor 10, New York for panels, presentations, networking, and a shared commitment to changing what's possible for women's health. Register at https://longevity.foundation/iih26

07/22/2026

The agenda for Invested in Her's in-person event on 8/14 is now live.

The Longevity Science Foundation will bring together clinicians, investors, philanthropists, founders, and advocates at 7 World Trade Center, New York, for an afternoon dedicated to one of healthcare and longevity's most underfunded areas: women's health.

We are excited to give all who come in person the opportunity to learn from the panels and presentations, meet innovators building companies at the intersection of longevity and women's health, and connect with one another meaningfully throughout the day.

This event is part of our Invested in Her campaign – raising money and awareness for critical research into menopause and ovarian aging to tackle downstream mortality risks that women face at unacceptably higher rates than men. Every donation directly supports research, with 100% of funds going to innovation.

The agenda is now available, and registration remains open: https://longevity.foundation/iih26. The room is capped at 85 seats.

If you cannot join us in New York but would still like to support the next generation of women's healthy longevity research, you can contribute to the campaign here: https://longevity.foundation/invested-in-her

07/20/2026

On 𝗔𝘂𝗴𝘂𝘀𝘁 𝟭𝟰, the Longevity Science Foundation is hosting the 𝗜𝗻𝘃𝗲𝘀𝘁𝗲𝗱 𝗶𝗻 𝗛𝗲𝗿 event: a curated afternoon for the investors, clinicians, philanthropists, interested parties, and operators who want to drive change in women’s health.

𝗧𝗵𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀:

📅 August 14, 2026 | 1:30 – 6:30 PM ET
📍 7 World Trade Center, Floor 10, New York
🎟️ 𝟴𝟱 𝘀𝗲𝗮𝘁𝘀. 𝗧𝗵𝗮𝘁'𝘀 𝘁𝗵𝗲 𝘄𝗵𝗼𝗹𝗲 𝗿𝗼𝗼𝗺.

𝗪𝗵𝗮𝘁'𝘀 𝗵𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗶𝗻𝘀𝗶𝗱𝗲:

→ Four panels covering the industry view on what change actually takes, the intersection of health, wealth, and career, funding underfunded health, and venture capital's role in women's health
→ A presentation from Oriana Papin-Zoghbi (CEO, AOA Dx) - the first company to generate a blood test for early detection of ovarian cancer
→ A highlight of companies inside the room building the future of women’s health
→ Real networking time, not a receiving line, to spark communication, build community, and engender action
Proceeds support our $𝟮𝟱𝟬,𝟬𝟬𝟬 𝗰𝗮𝗺𝗽𝗮𝗶𝗴𝗻 funding early-stage research into ovarian aging and menopause — the known, understudied drivers of cardiometabolic, neurodegenerative, and skeletal disease risk in women. 100% of donations go to the research. No overhead.

𝗥𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗼𝗽𝗲𝗻 𝗻𝗼𝘄. 85 seats, and this room is being built deliberately.

https://longevity.foundation/iih26

Thank you to our existing sponsors, and the ones soon to come, for making this possible: Silverstein Dream Foundation, Clear Inc., Tactical Tax Strategy, Revitalization Unlimited, and LongeVC.

Can't be in the room, but want to be a part of the movement investing in women’s health? You can still move the science forward:

https://longevity.foundation/invested-in-her

07/08/2026

Women's health platform O**m AI has raised AUD $4 million (~USD $2.77 million) in seed funding to expand its AI-powered platform designed to support women across different stages of life.

Founded by reproductive biology researcher Dr Ariella Heffernan-Marks, O**m envisions their platform as an ecosystem connecting women with services such as telehealth, home pathology testing, and digital pharmacies. According to the company, O**m's app has been downloaded more than 20,000 times, facilitated over 110,000 conversations, and is being trained on an anonymized dataset of more than 60,000 data points from women aged 15 to 84, contributed by users who opt in. The funding round, led by Admiralty Capital Group with participation from Antler, Giant Leap, LaunchVic, Foggy Valley Aotearoa, Aviron Investments, and Brisbane Angels, will support product development, team expansion, and continued women's health research.

Despite their profound influence on health across the lifespan, many aspects of female biology remain underfunded and understudied. Women have also been historically underrepresented in clinical research, leaving important gaps in our understanding of disease, treatment response, and prevention methodologies. As more companies develop technologies tailored to female physiology, investors are beginning to recognize opportunities in areas long overlooked.

Women’s biological priorities evolve from adolescence and the reproductive years through perimenopause, menopause, and later life. Each phase brings distinct changes that shape long-term health, making robust evidence across every stage of life essential to improving mitigation, diagnosis, and care.

Progress also depends on strengthening the scientific foundations that enable future diagnostics and interventions. Through our fundraising campaign, Invested in Her, we are raising $250,000 to support early-stage research in women's health, , and ovarian aging, helping generate the evidence needed to advance care for future generations. Learn more about the campaign here: https://longevity.foundation/invested-in-her

07/01/2026

Women's health startup Clair Health has raised $11.6 million in seed funding to develop a wearable designed specifically for hormonal health.

Founded by Stanford graduates Jenny Duan and Abhinav A., Clair Health is building a jewelry-inspired wrist device that, according to the company, combines 10 biosensors and more than 130 proprietary biomarkers to generate insights related to hormonal health, cycle irregularities, perimenopause, inflammation, and overall wellbeing. The company is backed by Khosla Ventures, with participation from startup accelerator program a16z speedrun, Brydge Club, Treehub, Cartan Capital, AGI House, Insiders VC, Anne Wojcicki, and Stephanie Coleman. Clair Health is currently testing the device with a closed group of beta users and plans to launch later this year.

The raise is another sign that women's health is beginning to attract greater scientific and, finally, commercial attention. Many of the most consequential aspects of female biology, including ovarian aging and the menopausal transition, remain inadequately studied despite their profound influence on health across the lifespan. Efforts to develop technologies specifically designed around female physiology underscore growing interest in addressing longstanding gaps in women's health research and care.

Whether emerging technologies can meaningfully improve our understanding of female biology and translate into better care will ultimately depend on continued scientific validation and deeper investment in women's health research. This is precisely why the Invested in Her campaign is raising $250,000 by September 1, 2026, to support early-stage research in women's health, menopause, and ovarian aging. Scientific progress depends not only on new technologies, but also on sustained investment in the fundamental biology that makes those innovations possible. For mothers, daughters, and women everywhere, it is time to get fully Invested in Her: https://longevity.foundation/invested-in-her

06/23/2026

We're pleased to welcome LongeVC as the official longevity sponsor of the Invested in Her campaign, focused on women's health, menopause, and ovarian aging.

LongeVC is a venture capital firm investing in breakthrough biotechnology and supporting early-stage founders working to bring scientific advances from research into real-world application. Through its portfolio and global network of scientists, entrepreneurs, and industry leaders, the firm helps accelerate the development of new approaches across medicine and biotechnology. LongeVC has supported the Longevity Science Foundation since its inception, and as part of its commitment to the Invested in Her campaign, has pledged a $25,000 matching contribution that will be unlocked if and once the fundraising goal is reached.

As an investor in early-stage science, LongeVC is closely engaged with areas where fundamental questions in medicine remain unresolved.

Addressing disparities in women’s health is both a scientific and ethical imperative. We're grateful to have LongeVC join this effort. Learn more about their work here: https://longevc.com

Women shouldn’t have to wait decades longer for their health to be properly understood and addressed. It’s time to get fully Invested in Her.

06/18/2026

We're pleased to welcome Revitalization Unlimited as the official historic real estate sponsor of the Invested in Her campaign, focused on women's health, menopause, and ovarian aging.

Revitalization Unlimited helps accredited investors access tax-efficient real estate opportunities by preserving historic commercial buildings that most funds overlook. The firm combines tax-efficient historic real estate as its anchor strategy with manufacturing acquisitions as a return enhancer, seeking to generate long-term value for investors while preserving important pieces of America's economic and architectural heritage.

The firm's focus on identifying overlooked opportunities resonates with the goals of Invested in Her. Women's health, menopause, and ovarian aging have received far less scientific attention and funding than their impact warrants, despite their profound influence on health, wellbeing, and quality of life across populations. Bringing greater scientific focus and investment to these areas is a necessary step toward strengthening the foundations of women's healthcare.

Addressing these disparities is both a scientific and ethical imperative. We're grateful to have Revitalization Unlimited join this effort. Learn more about their work here: https://revitalizationunlimited.com

Women shouldn’t have to wait decades longer for their health to be properly understood and addressed. It’s time to get fully Invested in Her.

06/17/2026

We're grateful to see the Invested in Her campaign featured by Longevity.Technology. Beyond fundraising, this initiative is about building momentum around questions that affect hundreds of millions of women worldwide. Every conversation, introduction, and contribution helps move the field forward and supports the researchers working to generate answers.

Thank you to Eleanor Garth, Phil Newman, and the Longevity.Technology team for helping bring visibility to our work. Read the full article here: https://longevity.technology/news/can-crowdfunding-change-ovarian-aging-research-and-opinions/

New Longevity Science Foundation campaign aims to raise funds – and public pressure – for overlooked driver of female healthspan.

Link as first comment.

06/12/2026

We're pleased to welcome Tactical Tax & Estate Planning (Tactical Tax Strategies) as the official tax strategy sponsor of the Invested in Her campaign, focused on Women's Health, Menopause, and Ovarian Aging.

Tactical Tax Strategies is a Scottsdale-based financial services firm specializing in tax mitigation, tax-efficient income, estate and retirement planning strategies, for more effective wealth transfer solutions. The firm works closely with financial advisors, attorneys, CPAs and their clients to translate complex financial structures into actionable planning.

Their decision to join the initiative reflects a shared recognition that this is not only a scientific gap but also an ethical one. Women's health has historically been underfunded and underprioritized, despite its direct impact on quality of life, family systems, and long-term healthspan outcomes. For Tactical Tax Strategies, this aligns with a simple but important idea: meaningful planning for the future must also account for how that future is lived, not just how it is financed.

Closing this gap is both a scientific and practical imperative. We're grateful to have Tactical Tax Strategies join this effort. Learn more about their work here: https://steptax.com/

Women shouldn’t have to wait decades longer for their health to be properly understood and addressed. It’s time to get fully Invested in Her.

06/10/2026

We’re pleased to welcome Clear Inc. as the official water sponsor of the Invested in Her campaign, supporting our efforts and funding research on women’s health, menopause, and ovarian aging.

Clear, a water purification systems company born from a personal encounter with waterborne illness, is redefining water quality in real estate. By installing, monitoring, and servicing trusted purification technology, Clear helps ensure that the water flowing through the buildings they serve is clean, safe, and healthy for thousands of families worldwide. Founded after its CEO experienced firsthand the consequences of unsafe water, the company approaches water quality as a foundational health issue rather than a simple building utility. Through centralized UV purification, real-time monitoring, and ongoing servicing, their prevention-first model extends beyond conventional water testing by focusing on microbial risks before they become a problem, demonstrating an approach to health that prioritizes prevention and long-term wellbeing.

Clear’s support reflects a belief that women’s health deserves greater scientific attention, investment, and urgency than it has historically received. Despite affecting billions of lives worldwide, research into female biology, ovarian aging, and menopause has long received less funding and focus than its impact warrants.

Clear, we are grateful for your support of research in women’s health, and your commitment to invest where it matters most. Together, we can generate insights that improve quality and length of life, reduce disease burden, and benefit generations of women to come.

We’re grateful to have Clear join this effort. Learn more about their work here: https://clear.inc/

Women shouldn’t have to wait decades longer for their health to be properly understood and addressed. It’s time to get fully Invested in Her.